Trinity Biotech Plc Share Price Today
(NASDAQ: TRIB)

Name: Trinity Biotech Plc Share Price Today (NASDAQ: TRIB) - Trinity Biotech Plc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Trinity Biotech Plc share price is $0.69 & ₹60.07 as on 6 Mar 2025, 2.30 'hrs' IST

$0.69

▲

0.03

(4.24%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Trinity Biotech Plc share price in Dollar and Rupees. Guide to invest in Trinity Biotech Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Trinity Biotech Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Trinity Biotech Plc share price movements

Today's Low: $0.66
Today's High: $0.69
$0.69
4.35%
Downside
Day's Volatility :4.76%
Upside
0.43%
52 Weeks Low: $0.63
52 Weeks High: $3.55
$0.69
9.41%
Downside
52 Weeks Volatility :82.39%
Upside
80.56%

Trinity Biotech Plc (TRIB) Returns

Period	Trinity Biotech Plc	Index (Russel 2000)
3 Months	-31.2%	0.0%
6 Months	-60.91%	0.0%
1 Year	-68.29%	0.0%
3 Years	-85.44%	-11.6%

Trinity Biotech Plc (TRIB) Key Statistics

in dollars & INR

Previous Close	$0.66
Open	$0.7
Today's High	$0.693
Today's Low	$0.66
Market Capitalization	$18.2M
Today's Volume	$49.9K
52 Week High	$3.55
52 Week Low	$0.6251
Revenue TTM	$59.1M
EBITDA	$-8.6M
Earnings Per Share (EPS)	$-2.13
Profit Margin	-34.39%
Quarterly Earnings Growth YOY	-0.77%
Return On Equity TTM	-1913.45%

How to invest in Trinity Biotech Plc Stock (TRIB) from India?

It is very easy for Indian residents to invest directly in Trinity Biotech Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Trinity Biotech Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Trinity Biotech Plc or TRIB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Trinity Biotech Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Trinity Biotech Plc shares which would translate to 1.262 fractional shares of Trinity Biotech Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Trinity Biotech Plc, in just a few clicks!

Returns in Trinity Biotech Plc (TRIB) for Indian investors in Rupees

The Trinity Biotech Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Trinity Biotech Plc investment value today

Current value as on today

₹36,862

Returns

₹63,138

(-63.14%)

Returns from Trinity Biotech Plc Stock

₹68,203 (-68.2%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Trinity Biotech Plc (TRIB)

-79%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Trinity Biotech Plc Stock from India on INDmoney has decreased by -79% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Trinity Biotech Plc

Perceptive Advisors LLC
6.50%
Hunter Associates Inc.
1.38%
Renaissance Technologies Corp
0.69%
Whitefort Capital Management, LP.
0.30%
Moss Adams Wealth Advisors LLC
0.09%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.08%

Analyst Recommendation on Trinity Biotech Plc

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Trinity Biotech Plc(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Trinity Biotech Plc Stock (TRIB)

What analysts predicted

Upside of 334.78%

Target:

$3.00

Current:

$0.69

Insights on Trinity Biotech Plc Stock (Ticker Symbol: TRIB)

Price Movement
In the last 6 months, TRIB stock has moved down by -61.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 15.84M → 15.15M (in $), with an average decrease of 4.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -6.75M → -4.75M (in $), with an average increase of 42.0% per quarter
TRIB vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 123.6%
TRIB vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 224.7%
Price to Sales
ForTRIB every $1 of sales, investors are willing to pay $0.1, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

TRIB Trinity Biotech Plc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$97.0M	↓ 2.12%
Net Income	$2.4M	↓ 105.93%
Net Profit Margin	2.46%	↑ 43.08%

	FY19	Y/Y Change
Revenue	$90.4M	↓ 6.8%
Net Income	$-4.1M	↓ 270.13%
Net Profit Margin	-4.5%	↓ 6.96%

	FY20	Y/Y Change
Revenue	$102.0M	↑ 12.77%
Net Income	$-6.0M	↑ 47.88%
Net Profit Margin	-5.9%	↓ 1.4%

	FY21	Y/Y Change
Revenue	$93.0M	↓ 8.84%
Net Income	$875.0K	↓ 114.55%
Net Profit Margin	0.94%	↑ 6.84%

	FY22	Y/Y Change
Revenue	$74.8M	↓ 19.56%
Net Income	$-41.0M	↓ 4785.94%
Net Profit Margin	-54.83%	↓ 55.77%

	FY23	Y/Y Change
Revenue	$56.8M	↓ 24.0%
Net Income	$-24.0M	↓ 41.42%
Net Profit Margin	-42.26%	↑ 12.57%

	Q2 FY23	Q/Q Change
Revenue	$14.7M	↓ 18.62%
Net Income	$-6.7M	↓ 33.3%
Net Profit Margin	-45.79%	↑ 10.08%

	Q3 FY23	Q/Q Change
Revenue	$14.7M	↑ 0.0%
Net Income	$-6.7M	↑ 0.0%
Net Profit Margin	-45.79%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$14.7M	↑ 0.18%
Net Income	$-3.3M	↓ 50.65%
Net Profit Margin	-22.56%	↑ 23.23%

	Q1 FY24	Q/Q Change
Revenue	$13.4M	↓ 8.68%
Net Income	$-5.5M	↑ 65.87%
Net Profit Margin	-40.97%	↓ 18.41%

	Q2 FY24	Q/Q Change
Revenue	$15.8M	↑ 17.98%
Net Income	$-6.8M	↑ 22.81%
Net Profit Margin	-42.65%	↓ 1.68%

	Q3 FY24	Q/Q Change
Revenue	$15.2M	↓ 4.36%
Net Income	$-4.8M	↓ 29.57%
Net Profit Margin	-31.41%	↑ 11.24%

	FY18	Y/Y Change
Profit	$41.4M	↓ 1.05%

	FY19	Y/Y Change
Profit	$38.1M	↓ 8.03%

	FY20	Y/Y Change
Profit	$48.6M	↑ 27.44%

	FY21	Y/Y Change
Profit	$38.1M	↓ 21.62%

	FY22	Y/Y Change
Profit	$22.0M	↓ 42.1%

	FY23	Y/Y Change
Profit	$19.5M	↓ 11.78%

	Q2 FY23	Q/Q Change
Profit	$4.3M	↓ 31.37%

	Q3 FY23	Q/Q Change
Profit	$4.3M	↑ 0.0%

	Q4 FY23	Q/Q Change
Profit	$5.0M	↑ 16.71%

	Q1 FY24	Q/Q Change
Profit	$4.1M	↓ 17.78%

	Q2 FY24	Q/Q Change
Profit	$5.7M	↑ 39.62%

	Q3 FY24	Q/Q Change
Profit	$5.3M	↓ 7.43%

	FY18	Y/Y Change
Operating Cash Flow	$6.9M	↓ 42.74%
Investing Cash Flow	$-17.4M	↑ 7.48%
Financing Cash Flow	$-17.0M	↑ 11.37%

	FY19	Y/Y Change
Operating Cash Flow	$5.5M	↓ 21.07%
Investing Cash Flow	$-11.9M	↓ 31.84%
Financing Cash Flow	$-4.0M	↓ 76.47%

	FY20	Y/Y Change
Operating Cash Flow	$23.8M	↑ 333.96%
Investing Cash Flow	$-10.2M	↓ 13.96%
Financing Cash Flow	$-2.7M	↓ 32.03%

	FY21	Y/Y Change
Operating Cash Flow	$13.2M	↓ 44.27%
Investing Cash Flow	$-7.1M	↓ 30.68%
Financing Cash Flow	$-6.0M	↑ 121.61%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-4.7M	↓ 305.01%
Investing Cash Flow	$27.9M	↓ 2196.46%
Financing Cash Flow	$-2.4M	↑ 31.76%

Trinity Biotech Plc Technicals Summary

Sell

Neutral

Buy

Trinity Biotech Plc is currently in a neutral trading position according to technical analysis indicators.

Trinity Biotech Plc (TRIB) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Trinity Biotech Plc	-26.02%	-60.91%	-68.29%	-85.44%	-88.24%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Trinity Biotech Plc	0.56	NA	1.3	-1.74	-19.13	-0.08	NA	-2.54
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Trinity Biotech Plc	Buy	$18.2M	-88.24%	0.56	-34.39%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Trinity Biotech Plc

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Organization	Trinity Biotech Plc
Employees	380
CEO	Mr. John Gillard
Industry	Health Technology

Management People of Trinity Biotech Plc

Name	Title
Mr. John Gillard	President, CEO, Company Secretary & Director
Mr. Ronan O'Caoimh A.C.A.	Founder, Director & Executive Advisor
Dr. James Walsh Ph.D.	Executive Director of Business Development & Executive Director
Ms. Louise Tallon	CFO & Chief Accounting Officer
Ms. Jacqueline O'Neill	Director of Operations
Dr. Gary Keating Ph.D.	Chief Technology Officer
Ms. Eibhlin Kelly	Chief Information Officer
Mr. Colm Molloy	Group Director of Human Resources & Culture
Mr. Adrian Donohue	Chief Commercial Officer

Important FAQs about investing in TRIB Stock from India :

What is Trinity Biotech Plc share price today?

Trinity Biotech Plc share price today stands at $0.69, Open: $0.70 ; Previous Close: $0.66 ; High: $0.69 ; Low: $0.66 ; 52 Week High: $3.55 ; 52 Week Low: $0.63.

The stock opens at $0.70, after a previous close of $0.66. The stock reached a daily high of $0.69 and a low of $0.66, with a 52-week high of $3.55 and a 52-week low of $0.63.

Can Indians buy Trinity Biotech Plc shares?

Yes, Indians can invest in the Trinity Biotech Plc (TRIB) from India.

With INDmoney, you can buy Trinity Biotech Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Trinity Biotech Plc at zero transaction cost.

How can I buy Trinity Biotech Plc shares from India?

It is very easy to buy Trinity Biotech Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Trinity Biotech Plc (TRIB) be purchased?

Yes, you can buy fractional shares of Trinity Biotech Plc with INDmoney app.

What are the documents required to start investing in Trinity Biotech Plc stocks?

To start investing in Trinity Biotech Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.